Supportive Understanding and Patient-centered Partnership for Optimizing Renal Treatment
SUPPORT
Using Community Health Workers and Trauma-Informed Care Training for Clinicians to Improve Kidney Disease Outcomes in a Diverse Urban Community
1 other identifier
interventional
153
1 country
1
Brief Summary
Black and Hispanic people face higher risks of chronic kidney disease (CKD) but have unequal access to the highest-quality kidney care. Black adults with CKD face 1.5 times higher hospitalization risks than non-Black adults with CKD. Once reaching end stage kidney disease (ESKD), Black patients are half as likely to receive a transplant and are often excluded from home dialysis. Structural racism creates complex barriers to optimal CKD care, providing an explanation for these findings. The Penn Medicine IMPaCT Community Health Worker (CHW) program is a rigorously tested approach to employ people from local communities to dismantle structural racism within health care systems and improve outcomes for marginalized patients. This trial will innovate by training CHWs to focus specifically on CKD care for minoritized people. The investigators will also train primary care clinicians caring for CKD patients on how to provide trauma-informed care (TIC). The first aim is to determine the feasibility, acceptability, and reach of a clinic-level TIC training to address the needs and concerns of Black and other minoritized patients. The second aim will be to conduct a three arm trial comparing individuals in usual care to individuals randomized to either our tailored CHW intervention in conjunction with clinic-level TIC training or to clinic-level TIC intervention only. The investigators will examine whether patients in the intervention arms have greater improvements in quality of life (primary). The investigators will also explore the impact of the interventions on patient activation, hospitalizations, and ESKD treatment preferences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedStudy Start
First participant enrolled
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2025
CompletedJanuary 15, 2026
January 1, 2026
1.4 years
April 17, 2024
January 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Kidney Disease Quality of Life Instrument (KDQOL)
KDQOL-36 is a short form that includes a generic score (the 12-Item Short Form Health Survey (SF-12), which includes the SF-12 Physical and Mental Component Summaries \[SF-12 PCS and MCS\]) and three CKD-specific subscales: 1) burden of kidney disease, 2) symptoms/problems of kidney disease, and 3) effects of kidney disease. Each of the KDQOL-36 kidney-targeted scales are scored by transforming all items linearly to a 0-100 possible range and averaging the items in the scale. On the KDQOL-36, higher scores indicate better health-related quality of life.
6 months
Secondary Outcomes (3)
Patient Activation Measure
6 months
All-Cause Hospitalizations
6 months
Patient preferences for end-stage renal disease treatment
6 months
Study Arms (3)
CHW + TIC
EXPERIMENTALPatients in this arm will receive 6 months of support from a community health worker as well as primary care from a clinic where clinicians and staff have undergone trauma-informed care training.
TIC only
EXPERIMENTALPatients in this arm will receive primary care from a clinic where clinicians and staff have undergone trauma-informed care training.
Usual Care
NO INTERVENTIONPatients in this arm will receive usual care.
Interventions
Primary care providers and staff at two General Internal Medicine clinics will receive training in providing supportive care to patients who have experienced trauma. The trainings are all action focused and include a review of racism in medicine, understanding intergenerational trauma and its impact on care, naming and mitigating barriers to health equity, and the basics of motivational interviewing
The IMPaCT intervention consists of three stages: goal-setting, tailored support, and connection with long-term support. CHWs first seek to understand the patient's individual circumstances, life histories, and priorities by using a semi-structured interview guide inquiring about social and behavioral determinants of health. CHWs will then partner with patients to create customized action plans based on patient needs.
Eligibility Criteria
You may qualify if:
- Chronic kidney disease stage 4 or 5
- Patient at participating general internal medicine or family medicine clinic
- Medicaid-eligible or uninsured
- Reside in high poverty Philadelphia zip code
You may not qualify if:
- No history of kidney transplant
- Not receiving any form of dialysis
- Not previously enrolled with a community health worker in the past 2 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn Medicine
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Research coordinators collecting baseline and outcomes data from participants will be blinded to arm.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sol Katz Professor of Medicine, University of Pennsylvania Perelman School of Medicine; Chief, Division of General Internal Medicine
Study Record Dates
First Submitted
April 17, 2024
First Posted
April 22, 2024
Study Start
June 17, 2024
Primary Completion
November 26, 2025
Study Completion
November 26, 2025
Last Updated
January 15, 2026
Record last verified: 2026-01